GLOBAL INSTRUMENTATION LIMITED

Financial Health Score: C- (Fair to Poor)

Explanation: The patient has a history of stability but has recently suffered a severe acute episode. While the business still maintains a positive net worth and has successfully paid down a significant portion of its short-term debts, it is hemorrhaging cash and sustaining heavy operational losses. The near-total depletion of its cash reserves is a critical symptom that requires immediate intervention.

Key Vital Signs

1. Blood Pressure (Cash Position): Critically Low - Cash at Bank: £22,047 (Down from £521,997 in 2024) - Interpretation: The company's cash reserves have plummeted by nearly 96% in a single year. This is the financial equivalent of hypotension—the business is surviving on minimal liquidity, leaving it highly vulnerable to any unexpected expenses or dips in revenue.

2. Internal Bleeding (Profitability): Severe Hemorrhage - Profit & Loss Reserve: £157,559 (Down from £562,624 in 2024) - Interpretation: The £405,065 drop in the P&L reserve indicates a substantial loss for the financial year. The core operations of the business are bleeding capital, which has directly consumed the equity built up in previous years.

3. Body Mass (Net Assets & Working Capital): Rapid Weight Loss - Net Assets: £496,556 (Down from £901,621 in 2024) - Net Current Assets: £398,668 (Down from £829,881 in 2024) - Interpretation: The company's overall net worth has shrunk by roughly 45%. While it remains in positive territory, the rapid deterioration means the financial "muscle" is wasting away.

4. Cholesterol (Liabilities): Cleared, but at a Cost - Current Liabilities: £553,048 (Down from £1,194,623 in 2024) - Long-term Liabilities: £0 (Down from £50,000 in 2024) - Interpretation: The business has successfully halved its short-term debts and cleared its long-term loans. However, paying off over £640k of debt while sustaining heavy operational losses is precisely what drained the cash reserves.

5. Immune System (Liquidity Ratio): Adequate - Current Ratio: 1.72 (Current Assets £951,716 / Current Liabilities £553,048) - Interpretation: Despite the cash crunch, the company technically has enough current assets (including £857k in debtors) to cover its current liabilities. The patient is not insolvent, but its health is highly dependent on collecting what it is owed.

Diagnosis

The patient is suffering from Acute Cash Depletion Syndrome with Operational Hemorrhage.

Looking at the history, Global Instrumentation Limited enjoyed relatively stable health from 2016 to 2024, typically maintaining net assets between £500k and £900k. However, the FY2025 results reveal a dramatic downturn. The business sustained a massive operating loss of approximately £405k.

To fund this loss and simultaneously pay off over £640k in short-term creditors, the company aggressively liquidated its assets: it collected roughly £635k from debtors (reducing the amount owed to them), sold £20k of investments, and burned through £500k of cash. The result is a company that has cleared its immediate debt obligations but has left itself with almost no cash to operate. The increase in stock from £10k to £72k also suggests that capital is tied up in unsold goods, further restricting liquidity. The patient has paid off its creditors but is now gasping for financial air.

Recommendations

To stabilize the patient and restore financial wellness, the following immediate interventions are prescribed:

1. Apply a Tourniquet to Cash Outflows: Implement immediate cash flow management. Freeze all non-essential capital expenditure and review all operating expenses to stop the operational bleeding.
2. Administer an IV (Emergency Liquidity): With only £22k in the bank, the company urgently needs a working capital facility. Secure an overdraft or short-term loan to ensure payroll and essential supplier obligations can be met while the business recovers.
3. Improve Circulation (Debtors & Stock): The £857k owed by debtors is the company's lifeline. Enforce stricter credit control and collection procedures to convert these receivables into cash immediately. Additionally, review the £72k of stock for potential clearance or discounting to accelerate cash conversion.
4. Vital Signs Monitoring: Institute rolling 13-week cash flow forecasts. The margin for error is now incredibly thin; management must know exactly when cash is coming in and going out to avoid cardiac arrest (insolvency).